Updated Jul 16, 2026 · Last SEC filing 2026-07-02
Edgewise Therapeutics, Inc. (EWTX) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 5 Form 8-K material event filings were reported by EWTX in the last 90 days. 2 Form 144 notices of proposed sale were filed for EWTX stock. InsiderAlpha tracks every EWTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001710072 |
| Form 4 filings (90d) | 9 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer | S — Open-market sale | 69.6K | $39.41 | $2.74M | SEC | |
| Russell Alan J | Chief Scientific Officer | S — Open-market sale | 130.4K | $39.41 | $5.14M | SEC | |
| Russell Alan J | Chief Scientific Officer | M — Option exercise | 69.6K | $0.18 | $13K | SEC | |
| Fox Jonathan C | Insider | A — Grant or award | 319 | $0.00 | — | SEC | |
| Russell Alan J | Chief Scientific Officer | M — Option exercise | 130.4K | $0.45 | $59K | SEC | |
| Donovan Joanne M. | CMO | S — Open-market sale | 50.0K | $38.57 | $1.93M | SEC | |
| Donovan Joanne M. | CMO | M — Option exercise | 50.0K | $7.08 | $354K | SEC | |
| Donovan Joanne M. | CMO | S — Open-market sale | 5.2K | $31.29 | $164K | SEC | |
| Fox Jonathan C | Insider | A — Grant or award | 339 | $0.00 | — | SEC | |
| Donovan Joanne M. | CMO | S — Open-market sale [10b5-1] | 28.7K | $32.31 | $926K | SEC | |
| Donovan Joanne M. | CMO | M — Option exercise [10b5-1] | 28.7K | $7.08 | $203K | SEC | |
| Donovan Joanne M. | CMO | M — Option exercise [10b5-1] | 21.3K | $7.08 | $151K | SEC | |
| Donovan Joanne M. | CMO | S — Open-market sale [10b5-1] | 21.3K | $32.12 | $685K | SEC | |
| Donovan Joanne M. | CMO | S — Open-market sale | 9.6K | $30.98 | $298K | SEC | |
| Donovan Joanne M. | CMO | S — Open-market sale | 6.7K | $30.98 | $209K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Edgewise Therapeutics, Inc. (EWTX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Russell Alan J | 6 | $7.95M |
| Donovan Joanne M. | 4 | $2.45M |
| Fox Jonathan C | 2 | — |
| Edris Badreddin | 2 | — |
| Morris Arlene | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in EWTX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live EWTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.